跳至主要内容
临床试验/CTRI/2022/08/044917
CTRI/2022/08/044917已完成4 期

Glycemic Index of an anti-diabetic oral nutritional supplement Vidavance

Dr Chetan Mehndiratta0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • Diabetic subjects ages 18-60 years
  • Fasting >120 mg / dL
  • No known food allergy or intolerance
  • Not taking any medications known to affect glucose tolerance.

排除标准

  • Subjects on special diet restriction
  • Pregnant and lactating mothers with a known history of diabetes mellitus
  • Presence of disease or drug(s) that may influence digestion and absorption of nutrients and a major medical or surgical event in the last 3 months

研究者

发起方
Dr Chetan Mehndiratta

相似试验

To check the relative ability of Vidavance to... | 临床试验